Reproductive System
Filtrar los productos
Marcas
Ver todas las marcas
Tecnologías
Ver todas las tecnologías
Reproductive System
Marcas
Ver todas las marcas
Tecnologías
Ver todas las tecnologías
Productos de Reproductive System
myChoice CDx PLUS
La prueba más completa para determinar el estado de deficiencia de la recombinación homóloga (HDR) estudiando los genes BRCA y 13 más adicionales, en pacientes con cáncer de ovario.
Myriad Genetics
HRD
Next Generation Sequencing (NGS)
myChoice CDx
The most comprehensive tumor test to determine Homologous Recombination Deficiency (HDR) Status by studying the BRCA genes in patients with ovarian cancer.
Myriad Genetics
Prognosis
Next Generation Sequencing (NGS)
EndoPredict®
Prognostic and predictive molecular in vitro test to determine the risk of recurrence and the absolute benefit of chemotherapy over the next 15 and 10 years, respectively, in patients with ER+/HER2- primary breast cancer.
Myriad Genetics
Prognosis
Real Time PCR (qPCR)
MiniHRS kit (Mini Homologous Recombination)
Study of 4 genes associated with breast and ovarian cancer.
SOPHIA Genetics
Reproductive System
Next Generation Sequencing (NGS)
Comunitary Solid Tumor Solutions
Analysis of 42 genes involved in the in the most common solid tumors: lung, colorectal, skin, and brain cancers
SOPHIA Genetics
Digestive System
Next Generation Sequencing (NGS)
LIQUIDPlex Universal solid tumor
NGS assay to study 28 genes commonly associated with solid tumor type cancers from circulating cell-free tumor DNA (ccfDNA/cfDNA/ctDNA).
Archer Dx
Digestive System
Next Generation Sequencing (NGS)